Unclaimed brand
A GlobalX Pharma fornece cerca de 50% da insulina distribuída pelo SUS no Brasil (dados de 2025). Conheça a caneta GlobalX U2 e nossos medicamentos e produtos.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#20B29D
Mountain Meadow
32, 178, 157
171, 70, 41
82, 0, 12, 30
#0F0F0F
Cod Gray
15, 15, 15
0, 0, 6
0, 0, 0, 94
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
GlobalX Pharma is a Sino-Brazilian pharmaceutical company founded in 2020 to connect international pharmaceutical innovation with the needs of Brazil’s public health system, the SUS. It develops international supply chains and partnerships to provide medicines and medical devices across all 26 Brazilian states and the Federal District, with a focus on access, quality, and continuity of treatment. The company says it supplied about half of the insulin distributed through the SUS in 2025 and has delivered insulin cartridges to the system since 2021.
Its portfolio and therapeutic areas include diabetes and insulin, rare diseases, oncology and rheumatology, and in-vitro diagnostic tests. Products include the GlobalX U2 insulin pen, designed with a larger dose window, improved grip, durable materials, and a precise dosing mechanism. GlobalX Pharma also manages a pipeline focused on biosimilars, generic medicines, and innovative treatments, aiming to offer alternatives in areas of complex care. Its work includes licensing and production partnerships, regulatory compliance with ANVISA, and active pharmacovigilance.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
The GlobalX Pharma name, logos and brand assets are trademarks of GlobalX Pharma and its affiliates. Brandfetch isn't affiliated with or endorsed by GlobalX Pharma. Their use is subject to GlobalX Pharma's brand guidelines.
